Is glucuronidation truly preserved in patients with liver disease?
Hoyumpa
A M
AM
Department of Medicine, University of Texas Health Science Center, San Antonio 78284-7878.
Schenker
S
S
D001798:Blood Proteins / Q000378:metabolism; D001921:Brain / Q000187:drug effects; D004702:Endocrine Glands / Q000503:physiopathology; D004790:Enzyme Induction; D004952:Esters / Q000378:metabolism; D004987:Ethers / Q000378:metabolism; D005965:Glucuronates / Q000378:metabolism*; D014453:Glucuronosyltransferase / Q000378:metabolism; D006801:Humans; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000201:enzymology / Q000473:pathology; D008107:Liver Diseases / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D009747:Nutritional Physiological Phenomena; D010084:Oxidation-Reduction; D010599:Pharmacokinetics
D001798:Blood Proteins; D004952:Esters; D004987:Ethers; D005965:Glucuronates; D014453:Glucuronosyltransferase